New Delivery System for Vaccines?

A thought crossed my mind when reading the report below.  I had no corroboration for it, so I kept it to myself–until now.
“insoluble and indigestible macromolecule that reacts to the protein assay, but cannot be recognized by any protein databases.”

[The abive no longer exists so look here]:

“In Infanrix Hexa we found:

chemical contamination from the manufacturing process or cross-contamination with other manufacturing lines; chemical toxins; bacterial peptide toxins; insoluble and indigestible macromolecule that reacts to the protein assay, but cannot be recognized by any protein databases.

Update 2020: I contacted an acquaintance who is a scientist.  I questioned the origin of the macromolecule’s design pointing him to this article I wrote in 2018.  He told me he would be seeing a member of the Corvelva team in a few days.  He never addressed my query again, but I see Corvelva added the following to the above paragraph in their paper.

“We have found instead a real polymer, insoluble and indigestible, that we supposed to be the set of antigens chemically bound together (has to be defined if this is present as an aggregate of the individual antigens or a single macromolecule), on which we can find in literature partial information regarding the single antigens.”

To my way of thinking, it is an experimental DNA origami.

We have not found:

Protein antigens of diphtheria toxoids, tetanus, pertussis, hepatitis B, Haemophilus influenzae B, Poliomyelitis 1-2-3; Formaldehyde and glutaraldehyde, Phenoxyethanol, antibiotic residues indicated in the composition; In Infanrix Hexa there are six antigens”

MIT worked on a transport package for the hexavalent vaccine.  Is this the reason no antigens were found was that they are in that macromolecule?  I wonder if the macromolecule is the transport?

Now don’t get me wrong.  MIT’s work is astounding.  The ramifications of such a delivery system could have many uses—some beyond what we can even dream about.  It’s exciting to see technology moving ever forward—but it must be with safety in mind.
Meanwhile–I saw a short clip buried in a youtube discussion of MIT’s work in creating the packages.  It’s only a few seconds, and it informs you that your baby can get one or two years of vaccines.  What if your baby has a reaction to the first round?  or the second?  or the third?  You’ll be told it’s a coincidence or it’s normal for your child to have raging fevers or febrile seizures or both.

The man working on some types of packages is here:
There are said to be in the order of 300 vaccines in the pipeline.  Is this how they will be delivered–in one fell swoop?
I saw a glimpse that some Italians were frightened because there were more “unexplained” baby deaths pretty soon (perhaps within hours) after being injected with this vaccine.  A hexavalent vaccine has just been approved for the USA by the FDA.

Has any scientific safety method testing with inert, saline placebo been done on it?  One group (control) with saline: One group (test) with the new formulation.
Typically safety testing is done against another vaccine or against a neurotoxic adjuvent.

If you view this article, you will see what one of the top businesses in the country thinks about disease.  You can see how disease is now a business.

Copyright 2018 Joyce Bowen About the Author:  Joyce Bowen is a freelance writer and public speaker.  Inquiries can be made at